The palliative care approach to nausea and vomiting

Auty, Simon
June 2006
GP: General Practitioner;6/2/2006, p26
The article presents information related to the palliative care approach to nausea and vomiting. Nausea is the unpleasant sensation that one feels when they need to vomit. Vomiting is the reflex action of propelling the contents of the stomach out through the mouth. Nausea and vomiting can affect many non-malignant palliative care patients and can be debilitating and distressing. The palliative care approach to nausea and vomiting tends to follow the physiological mechanisms and uses the classical non-drug and drug approach.


Related Articles

  • Pathophysiology and pharmacotherapy of nausea and emesis. Davis, W. Marvin // Drug Topics;10/18/99, Vol. 143 Issue 20, p96 

    Presents information on a study which reviewed the neural mechanism of nausea and vomiting, conditions that evoke response and approaches for their management. Neural basis of nausea and vomiting (NV); Pathophysiology of NV; Pharmacotherapy of NV; Conclusions.

  • Chemotherapy-Induced Nausea and Vomiting: Challenges and Opportunities for Improved Patient Outcomes. Hawkins, Rebecca; Grunberg, Steven // Clinical Journal of Oncology Nursing;Feb2009, Vol. 13 Issue 1, p54 

    Oncology nurses play a pivotal role in the care of patients receiving chemotherapy and are in a prime position to facilitate better care of patients experiencing chemotherapy-induced nausea and vomiting (CINV). However, to do so, they must be kept well apprised of the most recent guidelines, the...

  • Anticipatory nausea in cyclical vomiting. McRonald, Fiona E.; Fleisher, David R. // BMC Pediatrics;2005, Vol. 5, p3 

    Background: Cyclical Vomiting Syndrome (CVS) is characterised by discrete, unexplained episodes of intense nausea and vomiting, and mainly affects children and adolescents. Comprehending Cyclical Vomiting Syndrome requires awareness of the severity of nausea experienced by patients. As a...

  • Scope of management of nausea and vomiting in palliative care: review. Mohammed, Amrallah A.; Ghanem, Hahez // Pan Arab Journal of Oncology;Mar2014, Vol. 7 Issue 1, p30 

    Nausea and vomiting have long been presented as common and distressing symptoms affecting the majority of patients in; the specialist palliative care literature. However, recent surveys indicate that these symptoms may be less common than has previously been report. The backbone of the...

  • Perspektywy leaniczych zastosowaÅ„ kannabinoidów w chorobach przewodu pokarmowego. Rutkowska, Maria; Słupski, Wojciech; Sozański, Tomasz; Szeląg, Adam // Gastroenterologia Polska / Gastroenterology;2009, Vol. 16 Issue 6, p451 

    The endogenous cannabinoid system and its role in the physiology and pathophysiology of the digestive system is presented. The potential use of agonists and antagonists of cannabinoid receptors in such disorders as nausea and vomiting, peptic ulcer disease, gastroesophageal reflux disease,...

  • New Generation Agents for the Prevention of Chemotherapy-Induced Nausea and Vomiting. Sankhala, Kamalesh K.; Karnad, Anand B. // European Journal of Clinical & Medical Oncology;2011, Vol. 3 Issue 3, p10 

    Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant decline in quality of life in cancer patients. The morbidity due to CINV depends on the chemotherapeutic agent, the number of repeated cycles of treatment, and patient characteristics. Discontinuation of...

  • The cost of chemotherapy-induced nausea and vomiting in Italy. Enzo Ballatori; Fausto Roila; Benedetta Ruggeri; Stella Porrozzi; Mauro Iannopollo; Giancarla Soru; Giorgio Cruciani; Bruno Daniele; Maria Locatelli; James Pellissier; Robert Deuson // Supportive Care in Cancer;Jan2007, Vol. 15 Issue 1, p31 

    Abstract Goals of work?? The aim of this paper is to analyze the costs of chemotherapy-induced nausea and vomiting (CINV) in Italy. Materials and methods?? In this prospective observational study at seven public oncology centers, incidence and intensity of CINV daily for 8?days after...

  • Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting. Münstedt, K; Müller, H; Blauth-Eckmeyer, E; Stenger, K; Zygmunt, M; Vahrson, H // British Journal of Cancer;2/1/99, Vol. 79 Issue 3/4, p637 

    Dexamethasone (20 mg) or its equivalent in combination with 5-HT[SUB3] antagonists appears to be the gold-standard dose for antiemetic prophylaxis. Additional to concerns about the use of corticosteroids with respect to enhanced tumour growth or impaired killing of the tumour cells, there is...

  • Shenqi fuzheng, an injection concocted from chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. Ju Dong; Shi-Yue Su; Min-Yan Wang; Zhen Zhan // Journal of Experimental & Clinical Cancer Research (17569966);2010, Vol. 29, p137 

    Background: Platinum-based chemotherapy has been a standard therapy for advanced non-small cell lung cancer (NSCLC), but it has high toxicity. In China, Shenqi Fuzheng, a newly developed injection concocted from Chinese medicinal herbs has been reported that may increase efficacy and reduce...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics